tiprankstipranks
Arcus Biosciences Inc (RCUS)
NYSE:RCUS
US Market

Arcus Biosciences (RCUS) Balance Sheet

397 Followers

Arcus Biosciences Balance Sheet

Arcus Biosciences's total assets for Q4 2023 were $1.09B, a decrease of -8.06% from the previous quarter. RCUS total liabilities were $633.00M for the fiscal quarter, a -5.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 1.09B$ 1.34B$ 1.59B$ 772.29M$ 203.11M
Total Liabilities
$ 633.00M$ 688.00M$ 750.45M$ 269.99M$ 39.27M
Total Equity Gross Minority
$ 462.00M$ 657.00M$ 842.00M$ 502.30M$ 163.84M
Total Capitalization
$ 462.00M$ 657.00M$ 842.00M$ 502.30M$ 163.84M
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 15.24M$ 0.00
Currency in USD

Arcus Biosciences Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis